[go: up one dir, main page]

MXPA05012411A - Emulsion oleosa para sustitucion postnatal de hormonas. - Google Patents

Emulsion oleosa para sustitucion postnatal de hormonas.

Info

Publication number
MXPA05012411A
MXPA05012411A MXPA05012411A MXPA05012411A MXPA05012411A MX PA05012411 A MXPA05012411 A MX PA05012411A MX PA05012411 A MXPA05012411 A MX PA05012411A MX PA05012411 A MXPA05012411 A MX PA05012411A MX PA05012411 A MXPA05012411 A MX PA05012411A
Authority
MX
Mexico
Prior art keywords
oil emulsion
postnatal
hormone substitution
substitution
production
Prior art date
Application number
MXPA05012411A
Other languages
English (en)
Inventor
Frank Pohlandt
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of MXPA05012411A publication Critical patent/MXPA05012411A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

La invencion se relaciona con un procedimiento para la preparacion de emulsiones oleosas (emulsiones lipidicas) que contienen hormona, una emulsion oleosa isotonica que se puede obtener por tal procedimiento y el uso de la emulsion de acuerdo con la invencion para la preparacion de un medicamento para administracion intravenosa, especialmente para sustitucion postnatal de hormonas en bebes prematuros y para el tratamiento de dano neurologico despues de apoplejias.
MXPA05012411A 2003-06-18 2004-06-15 Emulsion oleosa para sustitucion postnatal de hormonas. MXPA05012411A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03013790A EP1488785A1 (de) 2003-06-18 2003-06-18 Ölemulsion zur postnatalen Hormonsubstitution
PCT/EP2004/051114 WO2004110402A1 (de) 2003-06-18 2004-06-15 Ölemulsion zur postnatalen hormonsubstitution

Publications (1)

Publication Number Publication Date
MXPA05012411A true MXPA05012411A (es) 2006-02-13

Family

ID=33395816

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05012411A MXPA05012411A (es) 2003-06-18 2004-06-15 Emulsion oleosa para sustitucion postnatal de hormonas.

Country Status (14)

Country Link
US (1) US20070071777A1 (es)
EP (2) EP1488785A1 (es)
JP (1) JP2006527736A (es)
CN (1) CN1809339B (es)
AT (1) ATE359061T1 (es)
BR (1) BRPI0410558A (es)
CA (1) CA2526567A1 (es)
DE (1) DE502004003483D1 (es)
ES (1) ES2281813T3 (es)
MX (1) MXPA05012411A (es)
PL (1) PL1633325T3 (es)
PT (1) PT1633325E (es)
RU (1) RU2318494C2 (es)
WO (1) WO2004110402A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155205B1 (en) * 2007-06-21 2011-12-21 Pantarhei Bioscience B.V. Treatment of meconium aspiration syndrome with estrogens
CN102202672A (zh) 2008-10-10 2011-09-28 达拉生物科学公司 使用穗霉素衍生物治疗或预防疼痛的方法
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
US20110206741A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation DHA Triglyceride Emulsions
WO2011103510A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha ester emulsions
EP2544707B1 (en) * 2010-03-09 2018-11-21 Dignity Health Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening
TW201138782A (en) * 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
LT2782584T (lt) * 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
EP2819649B1 (en) * 2012-02-29 2018-01-10 B. Braun Melsungen AG Hormone containing emulsion
TW201334808A (zh) * 2012-02-29 2013-09-01 Braun Melsungen Ag 含有荷爾蒙之包含磷蝦磷脂質的乳劑
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3193830B1 (en) 2014-09-19 2023-11-01 Heron Therapeutics, Inc. Emulson formulations of aprepitant
US9974742B2 (en) 2016-02-01 2018-05-22 Heron Therapeutics, Inc. Emulsion formulations of an NK-1 receptor antagonist and uses thereof
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CN1029293C (zh) * 1993-01-01 1995-07-12 浙江省中医院 薏苡仁中性油脂乳剂
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
CN1204238C (zh) * 2000-10-18 2005-06-01 李大鹏 从核桃仁中提取的核桃仁油组合物及其药物制剂

Also Published As

Publication number Publication date
CN1809339A (zh) 2006-07-26
AU2004246823A1 (en) 2004-12-23
ATE359061T1 (de) 2007-05-15
WO2004110402A1 (de) 2004-12-23
PL1633325T3 (pl) 2007-08-31
RU2318494C2 (ru) 2008-03-10
JP2006527736A (ja) 2006-12-07
US20070071777A1 (en) 2007-03-29
DE502004003483D1 (de) 2007-05-24
EP1633325A1 (de) 2006-03-15
CA2526567A1 (en) 2004-12-23
EP1488785A1 (de) 2004-12-22
BRPI0410558A (pt) 2006-06-20
EP1633325B1 (de) 2007-04-11
ES2281813T3 (es) 2007-10-01
RU2006101322A (ru) 2006-06-10
PT1633325E (pt) 2007-05-31
CN1809339B (zh) 2010-06-23

Similar Documents

Publication Publication Date Title
MXPA05012411A (es) Emulsion oleosa para sustitucion postnatal de hormonas.
TW200603831A (en) Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
JO2505B1 (en) Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
WO2005009398A3 (en) Tetracyclic benzamide derivatives and methods of use thereof
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
BRPI0922796A2 (pt) Comprimido farmacêutico para administração por via oral e método de fabricação do mesmo
NZ599292A (en) Vitamin d compositions and method of administration to a human being
WO2004091630A8 (ja) 眼に適用する疾患治療剤
BR112015022995A2 (pt) produto nutricional infantil com rrr-alfa-tocoferol
MX2022015799A (es) Composicion y metodo para el tratamiento del dolor cronico.
ZA200608407B (en) Method and composition for treating rhinitis
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
AR047726A1 (es) Metodos y reactivos para el tratamiento de trastornos inflamatorios
WO2005020959A3 (en) Novel drug compositions and dosage forms of topiramate
EP1575578A4 (en) METHOD FOR TREATING NERVOUS INJURY IN CONNECTION WITH BLEEDING
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
WO2004090537A3 (en) Methods to individualize combination therapy
IL157397A (en) Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy
Ali et al. Olanzapine induced neuroleptic malignant syndrome, treated with electroconvulsive therapy (ECT)—a case report
ATE303148T1 (de) Chinolin-harnstoff-derivate zur behandlung von entzugssyndrom und durch entzugssyndrom verursachten gehirnschaden
WO2004103291A3 (en) Extended release compositions of proton pump inhibitor
MD1780F1 (en) Method of treatment of patients with hepatic cirrhosis
EP1602374A4 (en) MEANS FOR TREATMENT OF MEDICAMENT / SUBSTANCE DEPENDENCE
WO2006042277A3 (en) Extended release compositions of proton pump inhibitors

Legal Events

Date Code Title Description
FG Grant or registration